ArticleStroke2016

Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.

Clinton B Wright et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.